Please check your internet connection and try again.
# Tobramycin Eye Drop
## Overview
Tobramycin is an aminoglycoside antibiotic indicated for the treatment of external ocular infections caused by susceptible bacteria. It prevents bacterial protein synthesis by binding to the 30S ribosomal subunit.
## Primary Indications
Treatment of external ocular infections and adnexa caused by susceptible strains of *Staphylococcus aureus*, *Staphylococcus epidermidis*, *Streptococcus* species, *Pseudomonas aeruginosa*, *Escherichia coli*, *Klebsiella pneumoniae*, *Enterobacter aerogenes*, *Proteus mirabilis*, *Morganella morganii*, *Haemophilus influenzae*, *Haemophilus aegyptius*, *Moraxella lacunata*, and *Acinetobacter calcoaceticus*.
## Adult Dosing
* **Mild to Moderate Infections:** 1–2 drops in the affected eye(s) every 4 hours.
* **Severe Infections:** 2 drops in the affected eye(s) hourly until improvement, then taper dose.
## Pediatric Dosing
* **Neonates (≥ 2 months) through Adolescents:** Same as adult dosing (1–2 drops every 4 hours or hourly for severe cases, depending on clinical severity).
## Dose Adjustments
No systemic dose adjustments are required for ophthalmic administration. Use should be limited to the minimum duration necessary to resolve the infection to prevent secondary fungal overgrowth or resistance.
## Contraindications
* Hypersensitivity to tobramycin or any component of the formulation.
## Adverse Effects
* **Common:** Ocular toxicity/hypersensitivity, including lid itching, lid swelling, and conjunctival erythema.
* **Rare:** Punctate keratitis, systemic absorption (if used excessively).
## Key Drug Interactions
* Minimal systemic absorption minimizes the risk of drug-drug interactions.
* Avoid simultaneous administration with other topical ophthalmic drugs (wait at least 5–10 minutes between products).
* Avoid concurrent use with other aminoglycosides (topical or systemic) as it may increase the risk of adverse reactions.
## Monitoring
* Monitor for clinical improvement (reduced redness, discharge, or pain) within 48–72 hours.
* Monitor for signs of hypersensitivity (excessive irritation or swelling).
* Prolonged use may result in the overgrowth of non-susceptible organisms, including fungi.
## Clinical Pearls
* **Administration:** Instruct patient to wash hands before use and avoid touching the tip of the dropper to the eye or skin.
* **Clinical Protocol:** Local institutional protocols and antibiograms may dictate usage for specific resistant organisms; if clinical response is poor, consider culturing the conjunctiva to rule out viral or fungal etiologies.
* **Discontinuation:** If signs of irritation occur, discontinue use immediately.
***
*Disclaimer: This information is for educational purposes and does not substitute for professional clinical judgment. Always verify current prescribing information, institutional protocols, and patient-specific factors before administration.*
